BriaCell Therapeutics (BCT) Stock Price, News & Analysis

Company Overview

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX:BCT) is dedicated to developing novel immunotherapies to fight cancer and improve patients' lives. Immunotherapies have become the forefront of the fight against cancer because they use the body's immune system to destroy cancer cells, offer the potential for higher levels of safety and efficacy than chemotherapy, and may also prevent cancer recurrence.

Key Stats

• Today's Range: C$4.45 to C$5.00
• 50-Day Range: C$3.80 to C$5.73
• 52-Week Range: C$3.68 to C$40.60
• Volume: 1,800 shs
• Average Volume: 20,567 shs
• Market Capitalization: C$39.59 million
• P/E Ratio: N/A
• Dividend Yield: 13.70%
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: TSE:BCT
• CIK: N/A
• Web: www.briacell.com
• Phone: 604-921-1810
• Fax: N/A
• Employees: 16
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C($0.84)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -C$2.37 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -147.92%
• Return on Assets: -122.71%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 7.07
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: C$3.23 per share
• Price / Book: 1.41

Miscellaneous

• Outstanding Shares: 8,700,000
• Free Float: N/A
• Market Cap: C$39.59 million
• Optionable: Not Optionable
• Beta: 1.98